Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 125,343 | 127,881 | 128,356 | 127,571 | 125,966 |
| Cost of Goods | 96,617 | 100,295 | 101,528 | 99,816 | 98,930 |
| Gross Profit | 28,726 | 27,586 | 26,828 | 27,755 | 27,036 |
| Operating Expenses | 14,671 | 8,975 | 20,875 | 12,953 | 13,321 |
| Operating Income | 14,672 | 18,906 | 6,481 | 15,618 | 14,645 |
| Interest Expense | 3,147 | 3,236 | 3,429 | 3,081 | 3,138 |
| Pre-tax Income | 11,525 | 15,670 | 3,052 | 12,537 | 11,507 |
| Income Tax | 2,305 | -7,259 | 610 | 5,847 | 3,856 |
| Net Income Continuous | 9,220 | 22,929 | 2,442 | 6,690 | 7,651 |
| Minority Interests | -37 | 83 | 69 | -61 | 127 |
| Net Income | $9,257 | $22,846 | $2,373 | $6,751 | $7,524 |
| EPS Basic Total Ops | 0.20 | 0.49 | 0.05 | 0.15 | 0.16 |
| EPS Basic Continuous Ops | 0.20 | 0.49 | 0.05 | 0.14 | 0.17 |
| EPS Diluted Total Ops | 0.19 | 0.48 | 0.05 | 0.15 | 0.16 |
| EPS Diluted Continuous Ops | 0.19 | 0.48 | 0.05 | 0.15 | 0.16 |
| EBITDA(a) | $18,601 | $22,843 | $10,525 | $19,691 | $18,816 |